Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells - PubMed (original) (raw)
. 2012 Sep 15;72(18):4629-41.
doi: 10.1158/0008-5472.CAN-12-1383. Epub 2012 Sep 7.
Affiliations
- PMID: 22962263
- DOI: 10.1158/0008-5472.CAN-12-1383
Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells
Muhammad Zaeem Noman et al. Cancer Res. 2012.
Abstract
Hypoxia in the tumor microenvironment plays a central role in the evolution of immune escape mechanisms by tumor cells. In this study, we report the definition of miR-210 as a miRNA regulated by hypoxia in lung cancer and melanoma, documenting its involvement in blunting the susceptibility of tumor cells to lysis by antigen-specific cytotoxic T lymphocytes (CTL). miR-210 was induced in hypoxic zones of human tumor tissues. Its attenuation in hypoxic cells significantly restored susceptibility to autologous CTL-mediated lysis, independent of tumor cell recognition and CTL reactivity. A comprehensive approach using transcriptome analysis, argonaute protein immunoprecipitation, and luciferase reporter assay revealed that the genes PTPN1, HOXA1, and TP53I11 were miR-210 target genes regulated in hypoxic cells. In support of their primary importance in mediating the immunosuppressive effects of miR-210, coordinate silencing of PTPN1, HOXA1, and TP53I11 dramatically decreased tumor cell susceptibility to CTL-mediated lysis. Our findings show how miR-210 induction links hypoxia to immune escape from CTL-mediated lysis, by providing a mechanistic understanding of how this miRNA mediates immunosuppression in oxygen-deprived regions of tumors where cancer stem-like cells and metastatic cellular behaviors are known to evolve.
Similar articles
- Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.
Akalay I, Janji B, Hasmim M, Noman MZ, André F, De Cremoux P, Bertheau P, Badoual C, Vielh P, Larsen AK, Sabbah M, Tan TZ, Keira JH, Hung NT, Thiery JP, Mami-Chouaib F, Chouaib S. Akalay I, et al. Cancer Res. 2013 Apr 15;73(8):2418-27. doi: 10.1158/0008-5472.CAN-12-2432. Epub 2013 Feb 22. Cancer Res. 2013. PMID: 23436798 - Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells.
Hasmim M, Noman MZ, Lauriol J, Benlalam H, Mallavialle A, Rosselli F, Mami-Chouaib F, Alcaide-Loridan C, Chouaib S. Hasmim M, et al. J Immunol. 2011 Oct 15;187(8):4031-9. doi: 10.4049/jimmunol.1101011. Epub 2011 Sep 12. J Immunol. 2011. PMID: 21911602 - A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
Barsoum IB, Smallwood CA, Siemens DR, Graham CH. Barsoum IB, et al. Cancer Res. 2014 Feb 1;74(3):665-74. doi: 10.1158/0008-5472.CAN-13-0992. Epub 2013 Dec 13. Cancer Res. 2014. PMID: 24336068 - Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G, Malorni W, Donelli G. Arancia G, et al. Ann Ist Super Sanita. 1990;26(3-4):369-84. Ann Ist Super Sanita. 1990. PMID: 2151107 Review. - miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.
Noman MZ, Janji B, Berchem G, Chouaib S. Noman MZ, et al. Cancer Lett. 2016 Sep 28;380(1):257-62. doi: 10.1016/j.canlet.2015.10.026. Epub 2015 Oct 30. Cancer Lett. 2016. PMID: 26523672 Review.
Cited by
- Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.
Xu Z, Chen Y, Ma L, Chen Y, Liu J, Guo Y, Yu T, Zhang L, Zhu L, Shu Y. Xu Z, et al. Mol Ther. 2022 Oct 5;30(10):3133-3154. doi: 10.1016/j.ymthe.2022.01.046. Epub 2022 Apr 9. Mol Ther. 2022. PMID: 35405312 Free PMC article. Review. - Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.
Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y, Zhao X, Lu C. Ren W, et al. J Exp Clin Cancer Res. 2019 Feb 8;38(1):62. doi: 10.1186/s13046-019-1027-0. J Exp Clin Cancer Res. 2019. PMID: 30736829 Free PMC article. - An integromic signature for lung cancer early detection.
Leng Q, Lin Y, Zhan M, Jiang F. Leng Q, et al. Oncotarget. 2018 May 15;9(37):24684-24692. doi: 10.18632/oncotarget.25227. eCollection 2018 May 15. Oncotarget. 2018. PMID: 29872497 Free PMC article. - CAR T-cell immunotherapy: The path from the by-road to the freeway?
Whilding LM, Maher J. Whilding LM, et al. Mol Oncol. 2015 Dec;9(10):1994-2018. doi: 10.1016/j.molonc.2015.10.012. Epub 2015 Oct 23. Mol Oncol. 2015. PMID: 26563646 Free PMC article. Review. - Synthesis and Evaluation of Chloroquine-Containing DMAEMA Copolymers as Efficient Anti-miRNA Delivery Vectors with Improved Endosomal Escape and Antimigratory Activity in Cancer Cells.
Xie Y, Yu F, Tang W, Alade BO, Peng ZH, Wang Y, Li J, Oupický D. Xie Y, et al. Macromol Biosci. 2018 Jan;18(1):10.1002/mabi.201700194. doi: 10.1002/mabi.201700194. Epub 2017 Aug 4. Macromol Biosci. 2018. PMID: 28776937 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous